By Priscila Mayumi Kashiwabara

The article “How to patent biological materials from 3D printing,” written by our partner Priscila Kashiwabara and patent specialist Breno Souza, has … Article “How to patent biological materials from 3D printing” for LSIPR

The National Health Surveillance Agency (ANVISA) has approved the opening of a Public Consultation to amend the regulation of biosimilar medicines in Brazil … Green light from ANVISA regarding the registration of biosimilar medicines in Brazil

The World Intellectual Property Organization (WIPO) has just published this year’s edition of its Global Innovation Index (GII). Among the 132 economies included in … Brazil climbs five positions and reaches Top 50 in WIPO’S Global Innovation Index 2023 Ranking

Check out the article “On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brasil”,  published on IAM Media, authored by … On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brazil

Last Friday, September 9th, the Brazilian FDA (ANVISA) published and made available new subject codes for submitting requests related to the Good … New subject codes for filing applications for GMP certification for biological products industries

Check out the article “Cannabis and IP: Nurturing innovation in Brazil’s life sciences industry”, authored by Priscila Kashiwabara and Luan Scalzitti and … Cannabis and IP: Nurturing innovation in Brazil’s Life Sciences industry

On May 9, 2023, the BPTO released the INPI/CPAPD technical opinion No. 01/2023, which provides guidance on the patentability of inventions related … The Brazilian PTO published a new technical opinion regarding the patentability of inventions related to transgenic plants

Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common … “Brazil: The patent combination conundrum” for LSIPR Magazine

Our partner Priscila Kashiwabara and specialists Breno Alves and Gabriel Cavalcante published the article “Sustainable agriculture, green technologies and IP in Brazil” in the Global Patent Prosecution Guide … Sustainable agriculture, green technologies and IP in Brazil

Our partner and head of Life Sciences, Priscila Kashiwabara discusses plant variety protection in Brazil and its recent developments regarding legal framework for Plant … Protecting Plant Varieties in Brazil for FloraCulture Magazine

On 7 June 2022, in the Official Gazette 2683, the Brazilian patent office published a communication regarding the new standard for submission … INPI publishes communication on new sequence listing standard for patent applications in Brazil

On March 17, 2022, the BPTO released the INPI/CPAPD technical note No. 01/2022, which provides guidance on the patentability of inventions involving … Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that … Life sciences patent eligibility in Latin America: a guide

On February 8th, 2022, the Brazilian Patent Office reported the decision to apostille letters-patent when the patent protects subject-matter going beyond the … News on apostille of letters-patent retroactively affected by the Direct Plea of Unconstitutionality 5,529

On December 28, 2021, the BRPTO published, by means of the Official Gazette nº 2660, the Ordinance #56/2021, which establishes the procedures … Sequence listing in ST.26 format is officially postponed until July 1, 2022 by the Brazilian PTO